Jianzhong Zhang

32PUBLICATIONS
85CO-AUTHORS
AllergyPharmaceutical delivery technologiesPharmacogenomicsAdolescent healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 03, 2026
Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

|Sep 02, 2026
52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

|May 03, 2026
Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial.

|Mar 23, 2026
HS-20137 for Chinese Moderate-to-Severe Psoriasis: A Randomized, Double-Blinded, Phase 2 Study.

Lin Cai, Xiaohua Wang, Litao Zhang

|Feb 16, 2026
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial.

Cheng Zhou, Yan Zhao, Guannan Zhu

|Feb 12, 2026
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study.

Lin Cai, Xiao-Yong Man, Jinyan Wang

Pageof 6

Frequent Collaborators

5 joint publications

Xiaoyong Man

4 joint publications

Xinghua Gao

3 joint publications

Yu-Qing Hu

3 joint publications

Yan Zhao